Melatonin and Radiation Therapy in Treating Patients With Brain Metastases
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
RATIONALE: Radiation therapy uses high-energy x-rays to damage tumor cells. Drugs such as
melatonin may make tumor cells more sensitive to radiation therapy and may protect normal
cells from the side effects of radiation therapy.
PURPOSE: Randomized phase II trial to determine the effectiveness of combining melatonin with
radiation therapy in treating patients who have brain metastases.